New pill tested to fight severe postpartum depression
Disease control
Completed
This completed Phase 3 trial tested whether an oral medication called LPCN 1154A could safely reduce severe depression symptoms in women with postpartum depression. The study involved 90 women who were within one year of giving birth and had severe depression. Participants were r…
Phase: PHASE3 • Sponsor: Lipocine Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC